`geom_smooth()` using method = 'gam' and formula 'y ~ s(x, bs = "cs")'
Quitting from lines 1563-1641 (ED_Markdown.Rmd)
| Summary | Values |
|---|---|
| Min | 1.00 |
| Quartile.1 | 1.00 |
| Median | 1.00 |
| Quartile.3 | 1.00 |
| Max | 10.00 |
| IQR | 0.00 |
| SD | 0.61 |
| Mean | 1.20 |
| Upper 95% CI | 2.42 |
| Lower 95% CI | -0.01 |
| Summary | Values |
|---|---|
| Min | 1.00 |
| Quartile.1 | 1.00 |
| Median | 1.00 |
| Quartile.3 | 1.00 |
| Max | 18.00 |
| IQR | 0.00 |
| SD | 1.23 |
| Mean | 1.45 |
| Upper 95% CI | 3.90 |
| Lower 95% CI | -1.01 |
| Ethnicity | Percentage (%) | Lower 95% CI | Upper 95% CI |
|---|---|---|---|
| Asian | 0.03 | 0.00 | 0.48 |
| Black | 92.30 | 91.85 | 92.76 |
| Coloured | 2.96 | 2.51 | 3.42 |
| Indian | 1.49 | 1.05 | 1.95 |
| Other | 0.16 | 0.00 | 0.62 |
| White | 3.06 | 2.61 | 3.51 |
| Gender | Percentage (%) | Lower 95% CI | Upper 95% CI |
|---|---|---|---|
| Female | 52.81 | 51.84 | 53.77 |
| Male | 47.14 | 46.17 | 48.11 |
| Other | 0.05 | 0.00 | 1.02 |
| Age Group | Percentage (%) | Lower 95% CI | Upper 95% CI |
|---|---|---|---|
| Infant | 0.28 | 0.00 | 1.27 |
| Preschool Child | 0.00 | 0.00 | 0.99 |
| Child | 1.48 | 0.49 | 2.46 |
| Adolescent | 4.02 | 3.03 | 5.00 |
| Young Adult | 6.00 | 5.02 | 6.99 |
| Adult | 34.09 | 33.11 | 35.08 |
| Middle Aged | 35.87 | 34.88 | 36.85 |
| Aged | 14.99 | 14.01 | 15.98 |
| 80+ | 3.28 | 2.29 | 4.26 |
7.97% of patient’s were assessed to have outlier length of stays. This was assessed by means of a cutoff of \(1.5*IQR\) below the first and above the third quartile.
3D Plot
2D Plot
| ICD Chapter | Percentage (%) | Lower 95% CI | Upper 95% CI |
|---|---|---|---|
| Infectious & Parasitic | 3.36 | 2.34 | 4.39 |
| Neoplasms | 18.67 | 17.66 | 19.71 |
| Blood & Immune | 0.48 | 0.00 | 1.51 |
| Endocrine, etc | 2.55 | 1.53 | 3.58 |
| Mental & Behavioural | 0.23 | 0.00 | 1.27 |
| Nervous System | 0.19 | 0.00 | 1.22 |
| Eye & Adnexa | 0.05 | 0.00 | 1.09 |
| Ear & Mastoid | 0.02 | 0.00 | 1.05 |
| Circulatory System | 5.37 | 4.35 | 6.40 |
| Respiratory System | 0.47 | 0.00 | 1.50 |
| Digestive System | 48.53 | 47.51 | 49.56 |
| Skin & Subcutaneous | 5.78 | 4.76 | 6.81 |
| Musculoskeletal | 1.15 | 0.13 | 2.18 |
| Genitourinary System | 2.96 | 1.94 | 3.99 |
| Pregnancy | 1.09 | 0.07 | 2.13 |
| Perinatal | 0.02 | 0.00 | 1.05 |
| Congenital | 0.45 | 0.00 | 1.48 |
| Abnormal Findings | 1.80 | 0.78 | 2.84 |
| Injury, Poisoning, etc | 1.00 | 0.00 | 2.03 |
| Morbidity & Mortality | 0.15 | 0.00 | 1.18 |
| Influencing Factors | 0.90 | 0.00 | 1.93 |
| Special Purpose | 0.01 | 0.00 | 1.04 |
| Neoplasm Morphology | 4.78 | 3.76 | 5.82 |
Analysis of predictors of a length of stay greater than 5 days in a surgical ward at a Wits institution.
| Fields | 5 or Less | More than 5 |
|---|---|---|
| Female | 3089 | 3025 |
| Male | 2496 | 2976 |
| Other | 3 | 2 |
| Fields | 5 or Less | More than 5 |
|---|---|---|
| Asian | 3 | 0 |
| Black | 5128 | 5538 |
| Coloured | 171 | 178 |
| Indian | 99 | 81 |
| Other | 10 | 5 |
| White | 177 | 201 |
| Fields | 5 or Less | More than 5 |
|---|---|---|
| Infant | 15 | 12 |
| Preschool Child | 0 | 0 |
| Child | 108 | 56 |
| Adolescent | 290 | 168 |
| Young Adult | 451 | 219 |
| Adult | 2096 | 1788 |
| Middle Aged | 1763 | 2441 |
| Aged | 691 | 1093 |
| 80+ | 174 | 226 |
| Fields | 5 or Less | More than 5 |
|---|---|---|
| Burns Unit | 0 | 1 |
| Trauma Unit | 0 | 2 |
| Unit 1 | 1743 | 2079 |
| Unit 3 | 1409 | 1729 |
| Unit 4 | 1160 | 697 |
| Unit 5 | 946 | 1028 |
| Unknown | 274 | 276 |
| Vascular | 56 | 191 |
| Fields | 5 or Less | More than 5 |
|---|---|---|
| Declined Treatment | 18 | 23 |
| Demised | 1 | 0 |
| Home | 4678 | 4995 |
| Other | 714 | 698 |
| Transfer | 177 | 287 |
| Fields | 5 or Less | More than 5 |
|---|---|---|
| Infectious & Parasitic | 131 | 211 |
| Neoplasms | 668 | 1248 |
| Blood & Immune | 21 | 29 |
| Endocrine, etc | 81 | 175 |
| Mental & Behavioural | 15 | 8 |
| Nervous System | 9 | 10 |
| Eye & Adnexa | 2 | 3 |
| Ear & Mastoid | 1 | 1 |
| Circulatory System | 178 | 346 |
| Respiratory System | 19 | 27 |
| Digestive System | 2526 | 2305 |
| Skin & Subcutaneous | 389 | 178 |
| Musculoskeletal | 43 | 83 |
| Genitourinary System | 200 | 93 |
| Pregnancy | 84 | 21 |
| Perinatal | 0 | 2 |
| Congenital | 20 | 23 |
| Abnormal Findings | 105 | 76 |
| Injury, Poisoning, etc | 55 | 45 |
| Morbidity & Mortality | 10 | 4 |
| Influencing Factors | 32 | 55 |
| Special Purpose | 0 | 2 |
| Neoplasm Morphology | 155 | 345 |
| Fields | 5 or Less | More than 5 |
|---|---|---|
| (A00-A09) Intestinal infectious diseases | 23 | 45 |
| (A15-A19) Tuberculosis | 17 | 35 |
| (A20-A28) Certain zoonotic bacterial diseases | 0 | 1 |
| (A30-A49) Other bacterial diseases | 9 | 31 |
| (A50-A64) Infections with a predominantly sexual mode of transmission | 18 | 16 |
| (A65-A69) Other spirochaetal diseases | 1 | 0 |
| (A80-A89) Viral infections of the central nervous system | 0 | 1 |
| (B00-B09) Viral infections characterized by skin and mucous membrane lesions | 3 | 0 |
| (B15-B19) Viral hepatitis | 6 | 5 |
| (B20-B24) Human immunodeficiency virus [HIV] disease | 20 | 41 |
| (B25-B34) Other viral diseases | 0 | 2 |
| (B35-B49) Mycoses | 10 | 4 |
| (B65-B83) Helminthiases | 5 | 14 |
| (B95-B98) Bacterial, viral and other infectious agents | 3 | 11 |
| (B99) Other infectious diseases | 16 | 5 |
| (C00-C14) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Lip, oral cavity and pharynx | 1 | 0 |
| (C15-C26) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Digestive organs | 311 | 878 |
| (C30-C39) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Respiratory and intrathoracic organs | 1 | 1 |
| (C40-C41) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Bone and articular cartilage | 0 | 1 |
| (C43-C44) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Skin | 4 | 17 |
| (C45-C49) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Mesothelial and soft tissue | 10 | 16 |
| (C50) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Breast | 195 | 170 |
| (C51-C57) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Female genital organs | 10 | 21 |
| (C60-C63) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Male genital organs | 6 | 3 |
| (C64-C68) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Urinary tract | 1 | 1 |
| (C69-C72) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Eye, brain and other parts of central nervous system | 0 | 1 |
| (C73-C75) Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue: Thyroid and other endocrine glands | 19 | 14 |
| (C76-C80) Malignant neoplasms of ill-defined, secondary and unspecified sites | 3 | 6 |
| (C81-C96) Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue | 5 | 6 |
| (C97) Malignant neoplasms of independent (primary) multiple sites | 0 | 2 |
| (D00-D09) In situ neoplasms | 15 | 27 |
| (D10-D36) Benign neoplasms | 62 | 50 |
| (D37-D48) Neoplasms of uncertain or unknown behaviour [see note, page 226] | 25 | 34 |
| (D50-D53) Nutritional anaemias | 16 | 12 |
| (D55-D59) Haemolytic anaemias | 2 | 2 |
| (D60-D64) Aplastic and other anaemias | 0 | 1 |
| (D65-D69) Coagulation defects, purpura and other haemorrhagic conditions | 1 | 2 |
| (D70-D77) Other diseases of blood and blood-forming organs | 1 | 11 |
| (D80-D89) Certain disorders involving the immune mechanism | 1 | 1 |
| (E00-E07) Disorders of thyroid gland | 36 | 35 |
| (E10-E14) Diabetes mellitus | 32 | 111 |
| (E15-E16) Other disorders of glucose regulation and pancreatic internal secretion | 1 | 3 |
| (E20-E35) Disorders of other endocrine glands | 9 | 20 |
| (E70-E90) Metabolic disorders | 3 | 6 |
| (F00-F09) Organic, including symptomatic, mental disorders | 1 | 2 |
| (F10-F19) Mental and behavioural disorders due to psychoactive substance use | 3 | 0 |
| (F20-F29) Schizophrenia, schizotypal and delusional disorders | 0 | 1 |
| (F30-F39) Mood [affective] disorders | 3 | 1 |
| (F40-F48) Neurotic, stress-related and somatoform disorders | 0 | 1 |
| (F50-F59) Behavioural syndromes associated with physiological disturbances and physical factors | 1 | 0 |
| (F70-F79) Mental retardation | 0 | 2 |
| (F90-F98) Behavioural and emotional disorders with onset usually occurring in childhood and adolescence | 1 | 0 |
| (F99) Unspecified mental disorder | 6 | 1 |
| (G00-G09) Inflammatory diseases of the central nervous system | 4 | 2 |
| (G10-G14) Systemic atrophies primarily affecting the central nervous system | 0 | 2 |
| (G40-G47) Episodic and paroxysmal disorders | 0 | 2 |
| (G50-G59) Nerve, nerve root and plexus disorders | 2 | 0 |
| (G70-G73) Diseases of myoneural junction and muscle | 2 | 2 |
| (G80-G83) Cerebral palsy and other paralytic syndromes | 1 | 1 |
| (G90-G99) Other disorders of the nervous system | 0 | 1 |
| (H00-H06) Disorders of eyelid, lacrimal system and orbit | 2 | 0 |
| (H25-H28) Disorders of lens | 0 | 2 |
| (H46-H48) Disorders of optic nerve and visual pathways | 0 | 1 |
| (H60-H62) Diseases of external ear | 1 | 0 |
| (H90-H95) Other disorders of ear | 0 | 1 |
| (I05-I09) Chronic rheumatic heart diseases | 3 | 1 |
| (I10-I15) Hypertensive diseases | 48 | 83 |
| (I20-I25) Ischaemic heart diseases | 2 | 3 |
| (I26-I28) Pulmonary heart disease and diseases of pulmonary circulation | 2 | 10 |
| (I30-I52) Other forms of heart disease | 6 | 7 |
| (I60-I69) Cerebrovascular diseases | 0 | 4 |
| (I70-I79) Diseases of arteries, arterioles and capillaries | 49 | 163 |
| (I80-H89) Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | 64 | 69 |
| (I95-I99) Other and unspecified disorders of the circulatory system | 4 | 6 |
| (J00-J06) Acute upper respiratory infections | 1 | 0 |
| (J09-J18) Influenza and pneumonia | 1 | 7 |
| (J20-J22) Other acute lower respiratory infections | 0 | 2 |
| (J30-J39) Other diseases of upper respiratory tract | 1 | 2 |
| (J40-J47) Chronic lower respiratory diseases | 8 | 7 |
| (J80-J84) Other respiratory diseases principally affecting the interstitium | 0 | 1 |
| (J85-J94) Other diseases of pleura | 3 | 5 |
| (J85-J94) Suppurative and necrotic conditions of lower respiratory tract | 5 | 2 |
| (J95-J99) Other diseases of the respiratory system | 0 | 1 |
| (K00-K14) Diseases of oral cavity, salivary glands and jaws | 3 | 2 |
| (K20-K31) Diseases of oesophagus, stomach and duodenum | 448 | 320 |
| (K35-K38) Diseases of appendix | 466 | 394 |
| (K40-K46) Hernia | 378 | 218 |
| (K50-K52) Noninfective enteritis and colitis | 14 | 11 |
| (K55-K64) Other diseases of intestines | 335 | 308 |
| (K65-K67) Diseases of peritoneum | 6 | 11 |
| (K70-K77) Diseases of liver | 15 | 66 |
| (K80-K87) Disorders of gallbladder, biliary tract and pancreas | 763 | 900 |
| (K90-K93) Other diseases of the digestive system | 98 | 75 |
| (L00-L08) Infections of the skin and subcutaneous tissue | 361 | 149 |
| (L10-L14) Bullous disorders | 2 | 0 |
| (L60-L75) Disorders of skin appendages | 3 | 5 |
| (L80-L99) Other disorders of the skin and subcutaneous tissue | 23 | 24 |
| (M00-M25) Arthropathies: Arthrosis | 1 | 1 |
| (M00-M25) Arthropathies: Infectious arthropathies | 1 | 2 |
| (M00-M25) Arthropathies: Inflammatory polyarthropathies | 5 | 4 |
| (M00-M25) Arthropathies: Other joint disorders | 0 | 2 |
| (M30-M36) Systemic connective tissue disorders | 2 | 1 |
| (M40-M54) Dorsopathies: Deforming dorsopathies | 4 | 1 |
| (M60-M79) Soft tissue disorders: Disorders of muscles | 5 | 10 |
| (M60-M79) Soft tissue disorders: Disorders of synovium and tendon | 2 | 1 |
| (M60-M79) Soft tissue disorders: Other soft tissue disorders | 19 | 54 |
| (M80-M94) Osteopathies and chondropathies: Chondropathies | 1 | 0 |
| (M80-M94) Osteopathies and chondropathies: Other osteopathies | 2 | 3 |
| (M800) Morphology Classification: Neoplasms, NOS | 6 | 26 |
| (M801-M804) Morphology Classification: Neoplasms, NOS | 3 | 11 |
| (M805-M808) Morphology Classification: Squamous cell neoplasms | 19 | 40 |
| (M809-M811) Morphology Classification: Basal cell neoplasms | 0 | 2 |
| (M812-M813) Morphology Classification: Transitional cell papillomas and carcinomas | 0 | 1 |
| (M814-M838) Morphology Classification: Adenomas and adenocarcinomas | 83 | 201 |
| (M844-M849) Morphology Classification: Cystic, mucinous and serous neoplasms | 5 | 2 |
| (M850-M854) Morphology Classification: Ductal and lobular neoplasms | 0 | 2 |
| (M868-M871) Morphology Classification: Paragangliomas and glomus tumours | 0 | 3 |
| (M872-M879) Morphology Classification: Naevi and melanomas | 0 | 2 |
| (M880) Morphology Classification: | 3 | 6 |
| (M881-M883) Morphology Classification: Fibromatous neoplasms | 3 | 12 |
| (M884) Morphology Classification: Myxomatous neoplasms | 0 | 1 |
| (M885-M888) Morphology Classification: Lipomatous neoplasms | 3 | 3 |
| (M889-M892) Morphology Classification: Myomatous neoplasms | 0 | 1 |
| (M893-M899) Morphology Classification: Complex mixed and stromal neoplasms | 2 | 18 |
| (M900-M903) Morphology Classification: Fibroepithelial neoplasms | 25 | 4 |
| (M904) Morphology Classification: Synovial-like neoplasms | 0 | 1 |
| (M906-M909) Morphology Classification: Germ cell neoplasms | 0 | 2 |
| (M912-M916) Morphology Classification: Blood vessel tumours | 0 | 1 |
| (M918-M924) Morphology Classification: Osseous and chondromatous neoplasms | 1 | 0 |
| (M95-M99) Other disorders of the musculoskeletal system and connective tissue | 1 | 4 |
| (M954-M957) Morphology Classification: Nerve sheath tumours | 1 | 2 |
| (M959-M971) Morphology Classification: Hodgkin and non-Hodgkin lymphoma | 0 | 3 |
| (M995-M997) Morphology Classification: Chronic myeloprpliferative disorders | 1 | 1 |
| (N10-N16) Renal tubulo-interstitial diseases | 7 | 9 |
| (N17-N19) Renal failure | 5 | 23 |
| (N20-N23) Urolithiasis | 0 | 1 |
| (N25-N29) Other disorders of kidney and ureter | 3 | 1 |
| (N30-N39) Other diseases of urinary system | 17 | 8 |
| (N40-N51) Diseases of male genital organs | 9 | 11 |
| (N60-N64) Disorders of breast | 120 | 14 |
| (N70-N77) Inflammatory diseases of female pelvic organs | 18 | 9 |
| (N80-N98) Noninflammatory disorders of female genital tract | 21 | 17 |
| (O00-O08) Pregnancy with abortive outcome | 0 | 6 |
| (O20-O29) Other maternal disorders predominantly related to pregnancy | 3 | 0 |
| (O60-O75) Complications of labour and delivery | 2 | 4 |
| (O80-O84) Delivery | 0 | 1 |
| (O85-O92) Complications predominantly related to the puerperium | 79 | 10 |
| (P80-P83) Conditions involving the integument and temperature regulation of fetus and newborn | 0 | 1 |
| (P90-P96) Other disorders originating in the perinatal period | 0 | 1 |
| (Q10-Q18) Congenital malformations of eye, ear, face and neck | 2 | 0 |
| (Q20-Q28) Congenital malformations of the circulatory system | 0 | 1 |
| (Q38-Q45) Other congenital malformations of the digestive system | 12 | 13 |
| (Q50-Q56) Congenital malformations of genital organs | 1 | 3 |
| (Q80-Q89) Other congenital malformations | 4 | 5 |
| (Q90-Q99) Chromosomal abnormalities, not elsewhere classified | 1 | 1 |
| (R00-R09) Symptoms and signs involving the circulatory and respiratory systems | 1 | 0 |
| (R10-R19) Symptoms and signs involving the digestive system and abdomen | 86 | 55 |
| (R20-R23) Symptoms and signs involving the skin and subcutaneous tissue | 15 | 8 |
| (R30-R39) Symptoms and signs involving the urinary system | 0 | 1 |
| (R50-R69) General symptoms and signs | 1 | 6 |
| (R70-R79) Abnormal findings on examination of blood, without diagnosis | 1 | 0 |
| (R83-R89) Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis | 1 | 0 |
| (R90-R94) Abnormal findings on diagnostic imaging and in function studies, without diagnosis | 0 | 6 |
| (S00-S09) Injuries to the head | 1 | 0 |
| (S10-S19) Injuries to the neck | 1 | 0 |
| (S20-S29) Injuries to the thorax | 0 | 1 |
| (S30-S39) Injuries to the abdomen, lower back, lumbar spine and pelvis | 5 | 25 |
| (S40-S49) Injuries to the shoulder and upper arm | 1 | 0 |
| (S70-S79) Injuries to the hip and thigh | 0 | 2 |
| (S80-S89) Injuries to the knee and lower leg | 1 | 2 |
| (S90-S99) Injuries to the ankle and foot | 2 | 0 |
| (T00-T07) Injuries involving multiple body regions | 1 | 0 |
| (T15-T19) Effects of foreign body entering through natural orifice | 5 | 0 |
| (T20-T32) Burns and corrosions: Burns and corrosions confined to eye and internal organs | 1 | 0 |
| (T20-T32) Burns and corrosions: Burns and corrosions of external body surface, specified by site | 3 | 0 |
| (T36-T50) Poisoning by drugs, medicaments and biological substances | 10 | 2 |
| (T51-T65) Toxic effects of substances chiefly nonmedicinal as to source | 17 | 2 |
| (T80-T88) Complications of surgical and medical care, not elsewhere classified | 7 | 11 |
| (U50) Drug resistant tuberculosis | 0 | 2 |
| (V01-V09) Accidents: Transport accidents: Pedestrian injured in transport accident | 0 | 1 |
| (W75-W84) Accidents: Other external causes of accidental injury: Other accidental threats to breathing | 4 | 0 |
| (X40-X49) Accidents: Other external causes of accidental injury: Accidental poisoning by and exposure to noxious substances | 0 | 1 |
| (X60-X84) Intentional self-harm | 6 | 0 |
| (X85-Y09) Assault | 0 | 1 |
| (Y83-Y84) Complications of medical and surgical care: Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure | 0 | 1 |
| (Z00-Z13) Persons encountering health services for examination and investigation | 1 | 1 |
| (Z40-Z54) Persons encountering health services for specific procedures and health care | 6 | 20 |
| (Z70-Z76) Persons encountering health services in other circumstances | 1 | 0 |
| (Z80-Z99) Persons with potential health hazards related to family and personal history and certain conditions influencing health status | 24 | 34 |
Wald Test
| Elements | Results | |
|---|---|---|
| Chi Squared | 29.9 |
|
| Degrees of Freedom | 2.0 |
|
| p Value | 0.0 | *** |
Fit Summary
| Elements | Results | |
|---|---|---|
| Null Deviance | 15862.42 |
|
| Null Degrees of Freedom | 11451.00 |
|
| Residual Deviance | 15832.47 |
|
| Residual Degrees of Freedom | 11449.00 |
|
| Akaike Information Criterion (AIC) | 15838.47 |
|
| Hoslem Test Chi-Squared | 11452.00 |
|
| Hoslem Degrees of Freedom | 8.00 |
|
| Hoslem p Value | 0.00 | *** |
Wald Test
| Elements | Results | |
|---|---|---|
| Chi Squared | 5.1400 |
|
| Degrees of Freedom | 4.0000 |
|
| p Value | 0.2733 |
|
Fit Summary
| Elements | Results | |
|---|---|---|
| Null Deviance | 15862.42 |
|
| Null Degrees of Freedom | 11451.00 |
|
| Residual Deviance | 15857.14 |
|
| Residual Degrees of Freedom | 11447.00 |
|
| Akaike Information Criterion (AIC) | 15867.14 |
|
| Hoslem Test Chi-Squared | 11452.00 |
|
| Hoslem Degrees of Freedom | 8.00 |
|
| Hoslem p Value | 0.00 | *** |
Wald Test
| Elements | Results | |
|---|---|---|
| Chi Squared | 332.39 |
|
| Degrees of Freedom | 7.00 |
|
| p Value | 0.00 | *** |
Fit Summary
| Elements | Results | |
|---|---|---|
| Null Deviance | 15862.42 |
|
| Null Degrees of Freedom | 11451.00 |
|
| Residual Deviance | 15518.43 |
|
| Residual Degrees of Freedom | 11444.00 |
|
| Akaike Information Criterion (AIC) | 15534.43 |
|
| Hoslem Test Chi-Squared | 11452.00 |
|
| Hoslem Degrees of Freedom | 8.00 |
|
| Hoslem p Value | 0.00 | *** |
Wald Test
| Elements | Results | |
|---|---|---|
| Chi Squared | 224.98 |
|
| Degrees of Freedom | 5.00 |
|
| p Value | 0.00 | *** |
Fit Summary
| Elements | Results | |
|---|---|---|
| Null Deviance | 15862.42 |
|
| Null Degrees of Freedom | 11451.00 |
|
| Residual Deviance | 15621.72 |
|
| Residual Degrees of Freedom | 11446.00 |
|
| Akaike Information Criterion (AIC) | 15633.72 |
|
| Hoslem Test Chi-Squared | 11452.00 |
|
| Hoslem Degrees of Freedom | 8.00 |
|
| Hoslem p Value | 0.00 | *** |
Wald Test
| Elements | Results | |
|---|---|---|
| Chi Squared | 20.0900 |
|
| Degrees of Freedom | 3.0000 |
|
| p Value | 0.0002 | *** |
Fit Summary
| Elements | Results | |
|---|---|---|
| Null Deviance | 15862.42 |
|
| Null Degrees of Freedom | 11451.00 |
|
| Residual Deviance | 15841.91 |
|
| Residual Degrees of Freedom | 11448.00 |
|
| Akaike Information Criterion (AIC) | 15849.91 |
|
| Hoslem Test Chi-Squared | 11452.00 |
|
| Hoslem Degrees of Freedom | 8.00 |
|
| Hoslem p Value | 0.00 | *** |
Wald Test
| Elements | Results | |
|---|---|---|
| Chi Squared | 492.25 |
|
| Degrees of Freedom | 17.00 |
|
| p Value | 0.00 | *** |